Triggers, symptoms, and treatment in two populations of migraneurs in Brazil and Spain. A cross-cultural study

Carod-Artal, Francisco Javier; Ezpeleta, David; Martín-Barriga, María L.; Peral, Á.L. Guerrero

doi:10.1016/j.jns.2011.02.027

Cited by 26 publications

(22 citation statements)

References 20 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…Odors as a trigger factor were seen in 18% of students which has been described in the past. [28–30] Olfactory hallucination or osmophobia can occur as a symptom complex in migraine. Indeed, a study did address this issue and they found that migraine may induce olfactory symptoms; olfactory pathology can trigger migraine or a common pathogen may induce both olfactory dysfunction and migraine.…”

Section: Discussionmentioning

confidence: 99%

Prevalence and characteristics of migraine in medical students and its impact on their daily activities

Menon

Kinnera

2013

Ann Indian Acad Neurol

View full text Add to dashboard Cite

Background:Migraine is a common neurological disorder with significant impact on quality of life. The aim of this study was to investigate the prevalence and characteristics of migraine headaches in medical students, to measure its impact on their life, and to assess their knowledge about the ailment. Information about lifestyle variables was also collected.Materials and Methods:All medical students who confirmed of having headache for more than 1 year formed the study group. Students filled a detailed questionnaire focusing on demographics, pain characteristics, accompanying factors, triggers, and family history of migraine. Lifestyle variables were enquired and migraine associated disability was assessed by MIDAS (Migraine Disability Assessment). The diagnosis of migraine was made according to the International Headache Society criteria. Results are expressed in n = numbers and percentage.Results:Sixty-eight percent of medical students had headache. The prevalence of migraine in the whole cohort was 28%; however, of the headache group, migraine constituted 42%. There was a female preponderance. One-fourth of the students had weekly or daily attacks with 31% students reporting increase in their headache intensity and frequency. Forty-four percent of students had severe headaches. Dizziness, allodynia, and neck stiffness were reported as accompanying symptoms. Trigger factors were identified in 99% students, predominant of which were poor sleep hygiene, environmental changes, head movements, and mental stress. Only 4% of students did regular exercise. Twenty-seven percent of students reported self-medication use of analgesics. One-fourth of the students had migraine-associated disability but only 6% realized that they had migraine.Conclusion:Our study found a high prevalence of headache with migraine in medical students. The students’ awareness of the disease was very low with one-fourth of the students resorting to self-medication. Our study identified previously less-recognized triggers like head movement and accompanying symptoms like neck stiffness. Migraine-attributed burden was high in medical students.

show abstract

Section: Discussionmentioning

confidence: 99%

Prevalence and characteristics of migraine in medical students and its impact on their daily activities

Menon

Kinnera

2013

Ann Indian Acad Neurol

View full text Add to dashboard Cite

show abstract

“…Only 21% of physicians reported using triptans as their first choice for treating attacks, although 31% had used triptans in the previous 3 months. It is very difficult to determine if these values are within expectations for a migraine population, as several variables influence triptan use by diagnosed migraineurs - in different countries it can vary between 16 and 47% [46]. A preference for non-triptan drugs is evident in our sample, which can relate to cost - the average out-of-pocket price of a triptan tablet in Portugal is EUR 4.47 while EUR 0.17 is the average unit price of ibuprofen, naproxen and paracetamol (values that already include partial reimbursement of the Portuguese National Health System) [47].…”

Section: Discussionmentioning

confidence: 99%

Headache from the Doctors' Perspective

Gil‐Gouveia¹

2014

Eur Neurol

View full text Add to dashboard Cite

Background: General practitioners (GPs) and neurologists are involved in treating headache patients in Portugal. Having migraine themselves might influence the way they perceive and treat migraine patients. Objective: To identify clinicians' perceptions about migraine, their own headache status and management of their own migraine. Methods: An observational cross-sectional survey of GPs and neurologists using anonymous questionnaires including demographic data, headache and migraine status and migraine perception questions. Results: Of 348 respondent physicians, 20% were neurologists and 53% were females with an average age of 48 years. The majority had an interest in migraine and considered it disabling (93%), although 65-85% reported management difficulties, GPs more often than neurologists. Satisfaction with current treatment options was high (69-79%). 63 physicians suffered from migraine and 81% felt it influenced their perception of the disease. Portuguese physicians preferentially treat their own migraines with NSAIDs (33%), analgesics (29%) and triptans (20%). Conclusion: Portuguese physicians treating migraine patients have realistic perceptions about the disease and those with migraine feel their perception is influenced by their experience. Although reporting management difficulties, the majority of physicians are satisfied with current treatment options for migraine.

show abstract

“…The absence of adequate preventive medication can favor the increase of migraine attacks. Population and cross-cultural studies have shown significant differences in the rate of migraine prevention 31. The second International Burden of Migraine Study (IBMS-II) showed that < one-half of CM patients were currently using any preventive medication 32.…”

Section: Risk Factors and Comorbiditymentioning

confidence: 99%

Tackling chronic migraine: current perspectives

Carod-Artal¹

2014

JPR

Self Cite

View full text Add to dashboard Cite

In the last decade, several diagnostic criteria and definitions have been proposed for chronic migraine (CM). The third edition of the International Classification of Headache Disorders–3 beta, published in 2013, has revised CM diagnostic criteria. CM is defined as “headache occurring on 15 or more days per month for more than 3 months, which has the features of migraine headache on at least 8 days per month.” Patients who meet the criteria for CM and for medication-overuse headache should be given both diagnoses. Worldwide, CM prevalence ranges 1%–3%, and its incidence has been estimated to be 2.5% per year. CM is associated with disability and poor quality of life. Modifiable risk factors include (among others): migraine progression (defined as an increase in frequency and severity of migraine attacks); medication and caffeine overuse; obesity; stressful life events; and snoring. CM patients have a significantly higher frequency of some comorbid conditions, including chronic pain, psychiatric disorders, respiratory illness, and some vascular risk factors. Management includes identification and control of comorbidities and risk factors that predispose to CM; treatment and prevention for medication overuse; early treatment for migraine attacks; and an adequate preventive therapy for CM. Several randomized controlled clinical trials have shown the efficacy of topiramate, amitriptyline, onabotulinumtoxinA, and cognitive-behavioral therapy in CM.

show abstract

Triggers, symptoms, and treatment in two populations of migraneurs in Brazil and Spain. A cross-cultural study

Cited by 26 publications

References 20 publications

Prevalence and characteristics of migraine in medical students and its impact on their daily activities

Prevalence and characteristics of migraine in medical students and its impact on their daily activities

Headache from the Doctors' Perspective

Tackling chronic migraine: current perspectives

Contact Info

Product

Resources

About